These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 30640748

  • 1. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
    Golubchik P, Shalev L, Tsamir D, Manor I, Weizman A.
    Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
    [Abstract] [Full Text] [Related]

  • 2. The effect of methylphenidate treatment on psychopathic behavior of patients having attention-deficit hyperactivity disorder with and without oppositional defiant disorder.
    Golubchik P, Levy T, Weizman A.
    Int Clin Psychopharmacol; 2018 Nov; 33(6):330-333. PubMed ID: 29958238
    [Abstract] [Full Text] [Related]

  • 3. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
    Golubchik P, Weizman A.
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):429-432. PubMed ID: 28398816
    [Abstract] [Full Text] [Related]

  • 4. The effect of methylphenidate treatment on suspiciousness in children with ADHD alone or comorbid with ODD.
    Golubchik P, Weizman A.
    Int J Psychiatry Clin Pract; 2018 Jun; 22(2):109-114. PubMed ID: 28959903
    [Abstract] [Full Text] [Related]

  • 5. A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression.
    Masi G, Manfredi A, Nieri G, Muratori P, Pfanner C, Milone A.
    J Clin Psychopharmacol; 2017 Oct; 37(5):590-594. PubMed ID: 28806385
    [Abstract] [Full Text] [Related]

  • 6. The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder.
    Serra-Pinheiro MA, Mattos P, Souza I, Pastura G, Gomes F.
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):399-402. PubMed ID: 15273834
    [Abstract] [Full Text] [Related]

  • 7. The effect of a single dose of methylphenidate on attention in children and adolescents with ADHD and comorbid Oppositional Defiant Disorder.
    D'Aiello B, Di Vara S, De Rossi P, Vicari S, Menghini D.
    PLoS One; 2024 Jun; 19(8):e0299449. PubMed ID: 39133690
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of Methylphenidate on Emotional Dysregulation in Children With Attention-Deficit/Hyperactivity Disorder + Oppositional Defiant Disorder/Conduct Disorder.
    Kutlu A, Akyol Ardic U, Ercan ES.
    J Clin Psychopharmacol; 2017 Apr; 37(2):220-225. PubMed ID: 28225747
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R.
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
    Pan PY, Fu AT, Yeh CB.
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
    [Abstract] [Full Text] [Related]

  • 15. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A, LYCY Study Group.
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [Abstract] [Full Text] [Related]

  • 16. Effect of OROS methylphenidate on encopresis in children with attention-deficit/hyperactivity disorder.
    Yılmaz S, Bilgiç A, Hergüner S.
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):158-60. PubMed ID: 24168715
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM.
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.